(h)MeDIP-Seq of high-risk prostate cancer
high-throughput sequencing of methylated and hydroxymethylated DNA from tumor and non-tumor tissue of patients with high-risk prostate cancer
- 06/05/2016
- 32 samples
- DAC: EGAC00001000260
- Technology: Illumina HiSeq 2000
Sequencing of high-risk primary prostate cancer samples: both whole exome sequencing and (h)MeDIP-Sequencing were performed within the Laboratory of Molecular Endocrinology at the KU Leuven, Belgium.
EGAC00001000262 KUL-MELList of terms and conditions for the usage of the data: please explain who you are, why you want to use the data and how this fits in your project. Contact persons: Frank ClaessensHerestraat 49, box 9013000 Leuven, Belgiumfrank.claessens@kuleuven.beLien Spans Herestraat 49, box 6023000 Leuven, Belgiumlien.spans@kuleuven.be
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001001019 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.